Protagonist Therapeutics Inc (PTGX)
Current ratio
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Total current assets | US$ in thousands | 355,577 | 243,077 | 340,736 | 315,606 | 145,311 |
| Total current liabilities | US$ in thousands | 21,274 | 31,179 | 44,016 | 40,241 | 35,406 |
| Current ratio | 16.71 | 7.80 | 7.74 | 7.84 | 4.10 |
December 31, 2023 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $355,577K ÷ $21,274K
= 16.71
Protagonist Therapeutics Inc's current ratio has exhibited an upward trend over the last five years, showing a substantial increase from 4.10 in 2019 to 16.71 in 2023. This indicates that the company's current assets are significantly higher than its current liabilities, suggesting strong liquidity and the ability to meet short-term obligations comfortably. The current ratio exceeding 1 indicates that the company has ample resources to cover its immediate liabilities. The steady improvement in the current ratio reflects positive financial stability and efficient management of working capital by Protagonist Therapeutics Inc. Overall, the increasing trend in the current ratio implies a healthier financial position for the company.
Peer comparison
Dec 31, 2023